Skip to main content
Screenshot of Anthropic's Super Bowl LX ad featuring a Black actor and text: "ads are coming to chatgpt. but not to claude."

Editorial illustration for Anthropic's Super Bowl LX ad omits OpenAI, ChatGPT references in AI‑focused spot

OpenAI Returns to Super Bowl with Bold AI Ad Pitch

Anthropic's Super Bowl LX ad omits OpenAI, ChatGPT references in AI‑focused spot

Updated: 3 min read

For an AI company founded by defectors who left OpenAI over safety concerns, Anthropic’s Super Bowl debut is a masterclass in the unspoken jab. Its four-spot campaign, trimmed to a thirty-second, $8 million slot, never utters “OpenAI” or “ChatGPT.” It doesn’t have to. The message is surgical: while OpenAI tests advertising on its chatbot, Anthropic promises Claude’s users won’t see sponsored links, won’t have advertisers whispering into their conversations, and won’t find product placements they never asked for. The ad doesn’t name the rival, but the dunk is unmistakable.

Anthropic, founded in 2021 by ex-OpenAI research executives who reportedly left over differences in opinions on AI safety and mission, doesn't mention OpenAI or ChatGPT by name in its Super Bowl Sunday ad campaign. But in contrast to OpenAI's January news that it would soon start testing ads, Anthropic says, "Our users won't see 'sponsored' links adjacent to their conversations with Claude; nor will Claude's responses be influenced by advertisers or include third-party product placements our users did not ask for." Read Article >- Anthropic's first Super Bowl ad dunks on ChatGPT. But not to Claude," is a clear shot at OpenAI's decision to bring ads to ChatGPT without mentioning it by name.

There are four commercials in the campaign, with one trimmed to thirty-seconds to air during the Super Bowl at a cost of around $8 million. - Don't expect any Kalshi or Polymarket ads during the Super Bowl. The NFL has added prediction markets to its list of "prohibited categories" for commercials in Super Bowl LX.

And so, in the span of thirty seconds and eight million dollars, Anthropic pulled off a quiet coup. It didn't name its rival. It didn't need to.

By promising what Claude will *never* do, serve you a sponsored thought, whisper a product placement into its reply, it drew a line in the silicon that feels sharper than any direct attack. The real message isn't about OpenAI. It's about trust.

While the prediction markets were benched by the NFL, and the other AI ads jostled for your fleeting attention, Anthropic chose to say what it *won't* become. That's a bet that might pay off long after the confetti is swept away.

Common Questions Answered

How much are AI companies spending on Super Bowl advertising in 2025?

AI companies increased U.S. TV advertising spending to $333.6 million in 2025, representing a 43% jump from the previous year. [blockonomi.com](https://blockonomi.com/openai-secures-second-super-bowl-ad-slot-as-ai-market-competition-intensifies/) reports that five major tech companies including OpenAI, Google, and Anthropic are investing heavily in television commercials to promote their AI technologies.

What did Google DeepMind CEO Demis Hassabis say about OpenAI's approach to advertising?

Hassabis expressed surprise that OpenAI was rushing to introduce ads in ChatGPT, stating he was 'a little bit surprised they've moved so early into that'. [techcrunch.com](https://techcrunch.com/2026/01/22/google-deepmind-ceo-is-surprised-openai-is-rushing-forward-with-ads-in-chatgpt/) quotes him as acknowledging that while ads have historically funded the consumer internet, there are questions about how ads fit into an AI assistant model.

How many weekly active users does ChatGPT currently have?

According to [blockonomi.com](https://blockonomi.com/openai-secures-second-super-bowl-ad-slot-as-ai-market-competition-intensifies/), ChatGPT currently serves over 800 million weekly users worldwide. The platform is facing increasing competition from rival AI services like Google's Gemini and Anthropic's Claude.

LIVE03:21OpenAI's Miles Wang in Talks for USD 2B AI Drug Discovery Startup